beta-HydroxyacteosideCAS# 109279-13-2 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
Cas No. | 109279-13-2 | SDF | Download SDF |
PubChem ID | N/A | Appearance | Powder |
Formula | C29H36O16 | M.Wt | 640.6 |
Type of Compound | Phenylpropanoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
beta-Hydroxyacteoside Dilution Calculator
beta-Hydroxyacteoside Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.561 mL | 7.8052 mL | 15.6104 mL | 31.2207 mL | 39.0259 mL |
5 mM | 0.3122 mL | 1.561 mL | 3.1221 mL | 6.2441 mL | 7.8052 mL |
10 mM | 0.1561 mL | 0.7805 mL | 1.561 mL | 3.1221 mL | 3.9026 mL |
50 mM | 0.0312 mL | 0.1561 mL | 0.3122 mL | 0.6244 mL | 0.7805 mL |
100 mM | 0.0156 mL | 0.0781 mL | 0.1561 mL | 0.3122 mL | 0.3903 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Isorhamnetin-3-O-rutinoside-7-O-glucoside
Catalog No.:BCX0005
CAS No.:55481-91-9
- Campneoside II
Catalog No.:BCX0004
CAS No.:95587-86-3
- Oxytroflavoside B
Catalog No.:BCX0003
CAS No.:1391144-81-2
- Kihadanin D
Catalog No.:BCX0002
CAS No.:2770024-83-2
- Quercetin 3,5-O-diglucoside
Catalog No.:BCX0001
CAS No.:206257-35-4
- (R)-Mucronulatol
Catalog No.:BCN9004
CAS No.:57128-11-7
- Isorhamnetin 3,5-O-diglucoside
Catalog No.:BCN1000
CAS No.:2035413-03-5
- Giganteone C
Catalog No.:BCN0999
CAS No.:1071223-56-7
- Cagayanin
Catalog No.:BCN0998
CAS No.:99096-51-2
- trans-Cinnamoyl beta-D-glucoside
Catalog No.:BCN0997
CAS No.:13080-39-2
- Benzylpropyl acetate
Catalog No.:BCN0996
CAS No.:7492-40-2
- Oxytroflavoside D
Catalog No.:BCN0995
CAS No.:1391144-83-4
- Massonianoside D
Catalog No.:BCX0007
CAS No.:85115-04-4
- Ganoweberianic acid E
Catalog No.:BCX0008
CAS No.:1309931-90-5
- Quercetin-3-O-[alpha-L-rhamnose-(1->2)-beta-D-glucopyranosyl]-5-O-beta-D-glucopyranoside
Catalog No.:BCX0009
CAS No.:1309795-36-5
- 4-O-Coumaroylquinic acid
Catalog No.:BCX0010
CAS No.:53539-37-0
- 2-(2,4-Dihydroxyphenyl)-5,6-methylenedioxybenzofuran (ABF)
Catalog No.:BCX0011
CAS No.:67121-26-0
- Ganolucidic acid B
Catalog No.:BCX0012
CAS No.:98683-75-1
- Ganoderenic acid G
Catalog No.:BCX0013
CAS No.:120481-73-4
- 10-Deacetylcephalomannine
Catalog No.:BCX0014
CAS No.:76429-85-1
- Hosenkoside D
Catalog No.:BCX0015
CAS No.:156823-94-8
- Dihydroconfertin
Catalog No.:BCX0016
CAS No.:68832-40-6
- Regaloside I
Catalog No.:BCX0017
CAS No.:126239-78-9
- Herbacetin 3-sophoroside-8-glucoside
Catalog No.:BCX0018
CAS No.:77298-68-1
A study of the precursors of the natural antioxidant phenol 3,4-dihydroxyphenylglycol in olive oil waste.[Pubmed:23578627]
Food Chem. 2013 Sep 1;140(1-2):154-60.
3,4-Dihydroxyphenylglycol (DHPG) is a potent antioxidant recently found in the free form in olive oil and table olives. DHPG can be recovered from olive oil solid waste by a hydrothermal treatment. It was observed that an increase in the concentration of DHPG occurred when alperujo aqueous extracts were subjected to mild thermal conditions (post-treatment). This fact indicates that certain solubilized compounds or precursors containing DHPG which is released with the post-treatment. In the present study, the precursors of DHPG were identified and characterized after extraction from alperujo using thermal treatment and purification by fractionation on Amberlite(R) XAD16 polyamide and semi-preparative reverse-phase HPLC columns. Their structures were elucidated using HPLC coupled to diode array detector (DAD) and electrospray ionization mass spectrometry (ESI-MS). The results identified three compounds as precursors, and their structures can be attributed to the diastereoisomeric forms of the two beta-hydroxy derivatives of verbascoside and isoverbascoside (beta-Hydroxyacteoside and beta-hydroxyisoacteoside), and 2''-hydroxyoleuropein, all of which contain a DHPG moiety, potentially explaining the increases in the concentration of this phenolic compound in olive oil waste.
Biosynthesis of acteoside in cultured cells of Olea europaea.[Pubmed:20037799]
J Nat Med. 2010 Apr;64(2):139-45.
Five phenylethanoid glycosides (acteoside, isoacteoside, beta-oxoacteoside, beta-Hydroxyacteoside, and salidroside) were isolated from a cell suspension culture of Olea europaea. We examined the biosynthesis of acteoside in olive cell cultures by using feeding experiments with stable isotope labeled precursors. The hydroxytyrosol moiety of acteoside is biosynthesized from tyrosine through dopamine, whereas the caffeoyl moiety of acteoside is biosynthesized from phenylalanine via a cinnamate pathway. Dopamine is incorporated into acteoside through oxidation to the corresponding aldehyde, reduction to the alcohol, and then beta-glycosylation.
Anti-inflammatory and antinociceptive potential of major phenolics from Verbascum salviifolium Boiss.[Pubmed:18533461]
Z Naturforsch C J Biosci. 2008 Mar-Apr;63(3-4):196-202.
The potential effects of flavonoids, phenylethanoid and neolignan glycosides from the aerial parts of Verbascum salviifolium Boiss. were studied in the p-benzoquinone-induced writhing reflex, for the assessment of the antinociceptive activity, and in carrageenan- and PGE1-induced hind paw edema and 12-O-tetradecanoyl-13-acetate (TPA)-induced ear edema models in mice, for the assessment of the anti-inflammatory activity. Through bioassay-guided fractionation and isolation procedures ten compounds from the aqueous extract of the plant, luteolin 7-O-glucoside (1), luteolin 3'-O-glucoside (2), apigenin 7-O-glucoside (3), chrysoeriol 7-O-glucoside (4), beta-Hydroxyacteoside (5), martynoside (6), forsythoside B (7), angoroside A (8), dehydrodiconiferyl alcohol-9'-O-beta-D-glucopyranoside (9) and dehydrodiconiferyl alcohol-9-O-beta-D-glucopyranoside (10), were isolated and their structures were elucidated by spectral techniques. Results have shown that 1, 2, 3 and 5 significantly inhibited carrageenan-induced paw edema at a 200 mg/kg dose, while 1, 2 and 5 also displayed anti-inflammatory activity against the PGE1-induced hind paw edema model. However, all the compounds showed no effect in the TPA-induced ear edema model. The compounds 1 and 2 also exhibited significant antinociceptive activity.
Screening for free radical scavenging and cell aggregation inhibitory activities by secondary metabolites from Turkish Verbascum species.[Pubmed:18069239]
Z Naturforsch C J Biosci. 2007 Sep-Oct;62(9-10):673-8.
Free radical scavenging and cell aggregation inhibitory activities of 36 secondary metabolites isolated from the methanolic extracts of Verbascum cilicicum Boiss., V. lasianthum Boiss. ex Bentham, V pterocalycinum var. mutense Hub.-Mor., and V. salviifolium Boiss. (Scrophulariaceae) were investigated. The isolated compounds, 6-O-vaniloyl ajugol (1), ilwensisaponin A (2), ilwensisaponin C (3), verbascoside (4), beta-Hydroxyacteoside (5), martynoside (6), poliumoside (7), forsythoside B (8), angoroside A (9), dehydrodiconiferyl alcohol-9-O-beta-D-glucopyranoside (10), dehydrodiconiferyl alcohol-9'-O-beta-D-glucopyranoside (11), apigenin 7-O-beta-glucopyranoside (12), luteolin 7-O-beta-glucopyranoside (13), luteolin 3'-O-beta-glucopyranoside (14) and chrysoeriol 7-O-beta-glucopyranoside (15), exhibited a dose-dependent inhibition of bioautographic and spectrophotometric DPPH activities. Verbascoside (4) was the most active (IC50 4.0 microg/ml) comparing it to vitamin C (IC50 4.4 microg/ml) to inhibit phorbol 12-myristate 13-acetate (PMA)-induced peroxide-catalyzed oxidation of 2',7'-dichlorofluorescein (DCFH) by reactive oxygen species (ROS) within human promyelocytic HL-60 cells. Ilwensisaponin A (2) (MIC 6.9 microg/ml) showed moderate in vitro activity on lymphocyte-associated antigen-1 (LFA-1)/intercellular adhesion molecule-1 (ICAM-1)-mediated aggregation using the HL-60 cell line [positive control was cytochalasin B (MIC 2.3 microg/ml)]. None of the other compounds showed free radical scavenging and cell aggregation inhibitory activities.